Literature DB >> 12887056

Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation.

Wu-Shiun Hou1, Zhenqiang Li, Frank H Büttner, Eckart Bartnik, Dieter Brömme.   

Abstract

Cathepsin K is a potent extracellular matrix-degrading protease that requires interactions with soluble glycosaminolycans for its collagenolytic activity in bone and cartilage. The major sources of glycosaminoglycans in cartilage are aggrecan aggregates. Therefore, we investigated whether cathepsin K activity is capable to hydrolyze aggrecan into fragments allowing the formation of glycosaminoglycan-cathepsin K complexes and determined the cleavage site specificity of cathepsin K toward the cartilage-resident link protein and aggrecan. The cleavage site specificity was compared with those of cathepsins S and L. All three cathepsins released glycosaminoglycans from native bovine cartilage at lysosomal pH and to a lesser degree at neutral extracellular pH. Cathepsin-predigested aggrecan complexes and cartilage provided suitable glycosaminoglycan fragments that allowed the formation of collagenolytically active cathepsin K complexes. A detailed analysis of the degradation of aggrecan aggregates revealed two cathepsin K cleavage sites in the link protein and several sites in aggrecan, including one site within the interglobular domain E1. In summary, these results demonstrate that cathepsin K is capable to degrade aggrecan complexes at specific cleavage sites and that cathepsin K activity alone is sufficient to self-provide the glycosaminoglycan fragments required for the formation of its collagenolytically active complex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887056     DOI: 10.1515/BC.2003.100

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  25 in total

1.  Influence of cell printing on biological characters of chondrocytes.

Authors:  Miao Qu; Xiaoyan Gao; Yikang Hou; Congcong Shen; Yourong Xu; Ming Zhu; Hengjian Wang; Haisong Xu; Gang Chai; Yan Zhang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Cordycepin modulates inflammatory and catabolic gene expression in interleukin-1beta-induced human chondrocytes from advanced-stage osteoarthritis: an in vitro study.

Authors:  Pengfei Hu; Weiping Chen; Jiapeng Bao; Lifeng Jiang; Lidong Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  Trichostatin A inhibits expression of cathepsins in experimental osteoarthritis.

Authors:  Wei-Ping Chen; Jia-Peng Bao; Jin-Li Tang; Peng-Fei Hu; Li-Dong Wu
Journal:  Rheumatol Int       Date:  2011-10       Impact factor: 2.631

4.  Ablation of cathepsin k activity in the young mouse causes hypermineralization of long bone and growth plates.

Authors:  Adele L Boskey; Bruce D Gelb; Eric Pourmand; Valery Kudrashov; Stephen B Doty; Lyudmila Spevak; Mitchell B Schaffler
Journal:  Calcif Tissue Int       Date:  2009-01-27       Impact factor: 4.333

Review 5.  Optimizing dentin bond durability: control of collagen degradation by matrix metalloproteinases and cysteine cathepsins.

Authors:  Leo Tjäderhane; Fabio D Nascimento; Lorenzo Breschi; Annalisa Mazzoni; Ivarne L S Tersariol; Saulo Geraldeli; Arzu Tezvergil-Mutluay; Marcela R Carrilho; Ricardo M Carvalho; Franklin R Tay; David H Pashley
Journal:  Dent Mater       Date:  2012-08-16       Impact factor: 5.304

Review 6.  Cathepsin K inhibitors for osteoporosis and potential off-target effects.

Authors:  Dieter Brömme; Fabien Lecaille
Journal:  Expert Opin Investig Drugs       Date:  2009-05       Impact factor: 6.206

7.  The imbalance between osteoprotegerin and cathepsin K in the serum of patients with longstanding rheumatoid arthritis.

Authors:  Martin Skoumal; Günther Haberhauer; Gernot Kolarz; Gerhard Hawa; Wolfgang Woloszczuk; Anton Klingler; Franz Varga; Klaus Klaushofer
Journal:  Rheumatol Int       Date:  2007-12-13       Impact factor: 2.631

8.  Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage.

Authors:  Valeria M Dejica; John S Mort; Sheila Laverty; M David Percival; John Antoniou; David J Zukor; A Robin Poole
Journal:  Am J Pathol       Date:  2008-05-29       Impact factor: 4.307

Review 9.  Genetically Engineered Mouse Models Reveal the Importance of Proteases as Osteoarthritis Drug Targets.

Authors:  Rachel E Miller; Yongzhi Lu; Micky D Tortorella; Anne-Marie Malfait
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

10.  Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions.

Authors:  Silvia Jordans; Sasa Jenko-Kokalj; Nicole M Kühl; Sofia Tedelind; Wolfgang Sendt; Dieter Brömme; Dusan Turk; Klaudia Brix
Journal:  BMC Biochem       Date:  2009-09-22       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.